th performance evaluation of a crs robot manipulator

12
Performance Evaluation of a CRS Robot Manipulator Applied to 3D-Ultrasound Imaging Marie-Ange Janvier Laboratory of Biorheology and Medical Ultrasonics, University of Montreal Hospital Research Center, Montreal, Canada. e-mail : [email protected] Surgical Robotics : 2 nd Summer European University, Montpellier, France September 7 th -14 th 2005.

Upload: others

Post on 02-Feb-2022

3 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: th Performance Evaluation of a CRS Robot Manipulator

Performance Evaluation of a CRS Robot Manipulator Applied

to 3D-Ultrasound ImagingMarie-Ange Janvier

Laboratory of Biorheology and Medical Ultrasonics, University of MontrealHospital Research Center, Montreal, Canada.

e-mail : [email protected]

Surgical Robotics : 2nd Summer European University, Montpellier, France September 7th-14th 2005.

Page 2: th Performance Evaluation of a CRS Robot Manipulator

Clinical applicationCardiovascular diseases are the leading cause of death for over 1/3 of Canadians.Degree of stenosis is the mostly used criterion to assess atherosclerosis.Appropriate therapy planning requires a complete 3D representation of the lower limb vessels.

http://adam.about.com/encyclopedia/18077.htm(29/08/225)

Page 3: th Performance Evaluation of a CRS Robot Manipulator

3D-US Systems

US offers many advantages :Low cost, non invasive, non-ionic, less traumatic, safe, painless, real-time, convenient, multiple analysis option.

2D-US does not provide an accurate evaluation of the 3D geometry !!!

http://www.phlebologia.com/en/anatomie_classique_04.asp (29/08/2005)

http://www.phlebologia.com/en/anatomie_classique_04.asp (29/08/2005)

Page 4: th Performance Evaluation of a CRS Robot Manipulator

Problem

Most 3D-US freehand tracking devices are not optimally adapted for quantifying a stenosis in lower limbs.

To identify tight stenoses in lower limbs, a scanning of high precision is required over a long segment.

Page 5: th Performance Evaluation of a CRS Robot Manipulator

Objectives

Evaluate the performance of a new medical prototype robot in terms of accuracy and repeatability.Evaluate the feasibility of accurate stenoses quantification with the robotic system.

Page 6: th Performance Evaluation of a CRS Robot Manipulator

Materials & MethodPrototype Medical Robot System

US Scanner Robotic ArmPC Workstation

Page 7: th Performance Evaluation of a CRS Robot Manipulator

Materials & MethodPrototype medical robot architecture

Power supply

E- Stop

Watchdog

Image acquisition cardNI-PCI 1411

US Scanner GE Vivid-5 US system

Replay : Operator button

Safety controlSafety control

Safety control

US probe

ATI F/T Sensor

CRS F 3 Robotic Arm

PC- Workstation URS Software

Robot ControllerC500C-CROS

ATI F/T sensor system controller

Teach mode

Teach/Replay mode Replay mode

Page 8: th Performance Evaluation of a CRS Robot Manipulator

Materials & MethodDesignated experimental zones

50 cm

35 cm

4 5

1 2

3

122 cm

121 cm121 cm

232.5 cm

61 cm

20..3 cm 22.5 cm

Robot

Workspace zones

Page 9: th Performance Evaluation of a CRS Robot Manipulator

Materials & MethodPreliminary 3D-reconstruction with a vascular

phantom. 1st stenosis79.5%

2nd stenosis69.9%

Vascular phantom (Cloutier et al., Med. Phys., 2004)

Page 10: th Performance Evaluation of a CRS Robot Manipulator

Results/DiscussionPerformance evaluation

0.003±0.540.62±0.290.10±0.22Mean

0.0035±0.500.58±0.220.081±0.165

0.0024±0.690.63±0.340.14±0.304

0.0027±0.540.61±0.290.086±0.183

0.0033±0.440.56±0.270.12±0.262

0.0036±0.530.72±0.300.0091±0.131

Mean inter-distance

Mean positioning

Zones Replay mode accuracyMeanrepeatability

Page 11: th Performance Evaluation of a CRS Robot Manipulator

Results/DiscussionPreliminary 3D-reconstruction

Area ratio reduction of the lumen

vessel

Phantom

model

3D-

Reconstruction

Ratio Error

Stenosis 1 79.5 % 76.03 % 3.47 % Stenosis 2 69.9 % 70.77 % 0.87 %

Page 12: th Performance Evaluation of a CRS Robot Manipulator

Acknowledgments

This work was supported in part by Canadian Institutes of Health Research (CIHR).This project was produced with the collaboration of an industrial partner : Integral Technologies Inc. , Laval, Québec, Canada (www. Integraltek.com).